Global Stem Cells Group has announced plans to inaugurate its new stem cell center in Quito, Ecuador with an inaugural conference and stem cell training event Feb. 24-March 6. The new facility will offer the latest stem cell therapies to treat a variety of patient needs.
MIAMI, Feb. 22, 2016—Global Stem Cells Group, has announced an inaugural conference and stem cell training event to launch its new stem cell treatment in Quito, Ecuador. Feb. 24-March 6, 2016 launch of a new stem cell treatment center in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine to patients from around the world.
Global Stem Cells Group CEO Benito Novas will host the event, which will begin with a stem cell conference featuring a renowned group of stem cell experts who will be featured speakers, including Global Stem Cells Group Chief Operating Officer Kipp Van Camp, D.O., Joseph Purita, M.D., and Pablo Cornejo, M.D. Purita, who heads GSCG’s Stem Cell Training, and Cornejo will perform a stem cell treatment on a high level Ecuadorian government official to address an orthopedic condition. The official cannot be named due to medical privacy standards.

The Conference will include a certified, hands-on, intensive two-day stem cell training course for Ecuadorian physicians on adipose-derived and bone marrow stem cell techniques.
The opening of the Quito stem cell clinic—the first in Ecuador—is part of Global Stem Cells Group’s expanding presence in Latin America.
“We’re excited to launch the Quito Global Stem Cells Group clinic and establish our services in Ecuador,” says Novas. “The Quito clinical staff of highly qualified and regarded physicians and medical professionals is enthusiastic about their roles as pioneers in bringing stem cell therapies to the country.”

Global Stem Cells Group has been expanding its clinical presence worldwide by partnering with qualified physicians experienced in stem cell therapies to open new clinics, licensed and developed under the GSCG banner.
The Quito event will be held at the Hotel Hilton Quito.
Global Stem Cells Group provides stem cell treatments for a variety of conditions and diseases including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, multiple sclerosis, injuries and more at various facilities worldwide. The new facility in Quito will have an

international staff that is experienced in administering the leading cellular therapies available.
Global Stem Cells Group’s Quito clinic is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. GSCG clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.
The Global Stem Cells Group is committed to providing the highest of standards of services and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.
For more information, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call +1 305 560 5337.
About the Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
To view this press release live online, click here

###

Global Stem Cells Group has announced the opening of a new stem cell clinic in Quito, Ecuador. The new facility will offer the latest stem cell and regenerative medicine treatments for orthopedic and trauma applications.

MIAMI, Feb. 11, 2016—Global Stem Cells Group, has announced the opening of its new stem cell treatment clinic in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine, focusing on orthopedic and trauma applications to patients from around the world.

The new GSCG clinic is headed by four prominent Ecuadorian physicians, including Pablo Ramos, M.D. an orthopedic specialist and attending physician at Metropolitan Hospital in Quito; Pablo Cornejo, M.D., a specialist in orthopedic and trauma surgery at Metropolitan Hospital, Quito; Luis Ernesto Mantilla, M.D., a specialist in trauma and knee Surgery,at Metropolitan Hospital, Quito, and Pablo Ramos, M.D., a specialist in trauma surgery and arthroscopy at Metropolitan Hospital, Quito.

The opening of the Quito stem cell clinic marks Global Stem Cells Group’s first facility in Ecuador, and is part of GSCG’s expanding presence in Latin America.
[su_spacer size=”10″]

Global Stem Cells Group has been expanding its clinical presence worldwide by partnering with qualified physicians experienced in stem cell therapies to open new clinics, licensed and developed under the GSCG banner.

Global Stem Cells Group provides stem cell treatments for a variety of conditions and diseases including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, multiple sclerosis, injuries and more at various facilities worldwide. The new facility in Quito will have an international staff that is experienced in administering the leading cellular therapies available.

Global Stem Cells Group’s Quito clinic is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. GSCG clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.

For more information, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call +1 305 560 5337.

About the Global Stem Cell Group:

Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

To view this press release live online, click here

###

Global Stem Cells Group, a world leader in regenerative medicine, has announced a new agreement with Bankok,Thailand-based Global Stem Cells Network (GSCN) to distribute exosome injection and other biological products to stem cell researchers and phsyicians in 15 Latin American countries, including Mexico, Costa Rica, Dominican Republic, Colombia, Argentina, Nicaragua, Panama, El Salvador, Venezuela, Peru, Ecuador, Paraguay, Puerto Rico, Chile Bolivia and Uruguay.

The agreement gives Global Stem Cells Group exclusive distribution rights for the following GSCN products:

• Exosome Injection, a human induced pluripotent stem cell-derived mesenchymal stem cell treatment, which has emerged as a promising supplement to stem cell transplantation therapies. Exosomes derived from mesenchymal stem cells can play an important role in repairing injured tissues. Exosome injection is also utilized as a complement to bone marrow stem cell extractions.
• GcMaf ( Goleic) Injections, a breakthrough technology used to counteract the effects of immune system suppression caused by cancerous tumor cells. Complementary oncology utilizes GcMAF therapy to boost the patient’s immune system. Peer reviewed studies have proven that GcMAF Goleic therapy is an immune activator, and can be used as a natural cancer treatment. GcMAF Goleic inhibits blood supply to tumors, activates self-destruction of cancer cells, reverts cancer cells’ characteristics to normal healthy cells, reduces the metastatic potential of human cancer cells and increases energy production at the mitochondrial level.
• Myopep Injection provides a potentially integral part of muscular enhancement and sports medicine rehabilitation, as well as therapeutic care for type 2 diabetes-related weight issues, obesity-related weight loss, aging-related muscle wasting and cerebral palsy. Myopep utilizes bio-engineered peptides to effectively inhibit myostatin, the growth and differentiation factor found in muscle receptor sites. Successful clinical trials demonstrate significant fat loss and muscle gain. Myopep is capable of inducing a pharmaceutical grade effect in human muscle and adipose fat function. Metabolism or glycolysis (sugar metabolism) rises, forcing fat to be broken down into sugar to feed muscular action and growth, causing increased muscle growth, definition and strength. One subcutaneous injection of Myopep at the abdominal area weekly over a period of two months has shown significant fat loss in clinical trials, and a significant drop in glucose metabolic parameters.

“Global Stem Cells Group strives to remain in the forefront of non-invasive, natural medical therapies that provide options for patients who are not finding relief through traditional treatments, and GSCN’s biological products are valuable in achieving these goals,” says Global Stem Cells Group CEO Benito Novas. “As the exclusive distributor of GSNC products in Latin America, this is an excellent opportunity to offer patients access to the most cutting-edge natural remedies available.”

For more information, visit the Global Stem Cells Group website, email info(at)stemcelltraining(dot)net, or call (305) 560-5337.

About Global Stem Cell Group:

Global Stem Cells Group is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

About Global Stem Cells Network (GSCN):

Bangkok, Thailand-based Global Stem Cells Network is made up of internationally-trained physicians and health care professionals dedicated to providing the safest, most effective stem cell treatments available today. GSCN is a recognized and trusted leader in providing stem cell specialist treatment programs since 2010, and related medical care since 2003.

To view this press release live online, click here.

###

Global Stem Cells Group has announced a new agreement with Bangkok, Thailand-based Global Stem Cells Network and its affiliate Global Medical Training Network for qualified physician referrals from the Philippines, Thailand and Singapore to be trained in the latest stem cell therapies.

MIAMI, Fla., Feb. 10, 2016—Global Stem Cells Group, a world leader in regenerative medicine, has announced a new agreement with Singapore-based Global Stem Cells Network (GSCN) and its affiliate Global Medical Training Network to train qualified physicians from the Philippines, Thailand and Singapore in the latest adipose and bone marrow therapies.

Through the new collaboration, Global Stem Cells Group and its Affiliate Stem Cell Training, Inc. have scheduled six, two-day intensive “Adipose and Bone Marrow Training Course” programs at its training facilities in several cities around the world for GSCN-referred physicians between March and October, 2016.

In addition, Global Stem Cells Group will host training for its graduate course, “Diplomat in Cell Therapy and Tissue Engineering” in June and December, 2016.

Global Stem Cells Group CEO Benito Novas says the agreement with GSCN and Global Medical Training Network is the latest in the international biotech company’s ongoing expansion efforts to bring stem cell treatments to communities worldwide.

“We are very pleased to be working with GSCN, and see this as a great opportunity to prove how valuable a collaboration between two international stem cell providers with the same goals can be,” Novas says.

GSCN’s Global Medical Training Network is made up of industry leaders, specialist physicians and researchers who have joined together to offer breakthrough information and training on the latest medical innovations, products and consumer trends in regenerative and anti-aging medicine.

“Though our collaboration with Global Stem Cells Group, we are confident that our goal to make stem cell medicine a cornerstone of best medical practices worldwide is at hand, and we’re excited to be in the forefront of the future of regenerative medicine,” says GSCN Finance Manager Zunaid Ibne Raihan.

For more information, visit the Global Stem Cells Group website, email info(at)stemcelltraining(dot)net, or call (305) 560-5337.

About Global Stem Cell Group:

Global Stem Cells Group is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

About Stem Cells Training:

Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.

The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.

About Global Stem Cells Network (GSCN):

Bangkok, Thailand-based Global Stem Cells Network is made up of internationally-trained physicians and health care professionals dedicated to providing the safest, most effective stem cell treatments available today. GSCN is a recognized and trusted leader in providing stem cell specialist treatment programs since 2010, and related medical care since 2003.

About Global Medical Training Network (GMTN):

Global Medical Training Network offers a platform for like-minded physicians and other healthcare professionals to further their own education, enhance their medical practice and incorporate cutting edge procedures and products that work.

Uniquely positioned at the center of an ambitious healthcare group, GMTN specializes in integrative medicine, owns and operates several clinics and two medical tourism companies, supports research projects and maintains close ties with advanced regional product distributors. GMTN provides access to the latest stem cell and regenerative medicine information through trainings, lectures, webinars, EDMs and social networks.

Global Stem Cells Group will present the largest global network of medical leaders and physicians from an array of disciplines and practices worldwide, as well as their representatives, franchises and partners at the 2016 International Academic Year Inaugural Convention March 25, 25 and 27 in Santiago, Chile.

 

MIAMI, Jan. 19, 2016—Global Stem Cells Group, a world leader in regenerative medicine, will host the 2016 International Academic Year Inaugural Convention March. 25-27, 2016 in Santiago, Chile. The convention will kick off the New Year by gathering the largest global network of medical leaders and physicians from around the world to formally sign a joint venture between GSCG and Santiago-based Cellus Regenerative Medicine, SA.
Global Stem Cells Group COO Kipp Van Camp will be in Santiago to execute the agreement between GSCG and Cellus, and to supervise GSCG’s new facilities and protocols to be used in its medical tourism initiative.
David Audley, Chair and General Secretary of the Regentech Alliance (RTA), will be on hand to conduct the GSCG Chile facility’s RTA certification process. The RTA certification signifies that GSCG Chile meets the highest standards of excellence in current medical and laboratory practices as measured by established standards.
The mission of the conference s to educate the medical community on the latest advances in regenerative medicine, and will feature experts in regenerative medicine, including:
Spain
•  Augusti Molins, M.D.  of the Medical Center in Barcelona. Molins specializes in nutrition and dietetics, the protein diet Sulço® method, obesity and overweight children, ozone therapy, carboxitherapy, aesthetic medicine cosmetic surgery. Spain.

U.S.
•  Michel Garcia, M.D., internist, American Academy of Anti- Anti-Aging Medicine (A4M) and director of the Hornnofit Center in Coral Gables, Florida.
U.S.
•  Kipp Van Kamp, D.O., interventional radiologist, Global Stem Cells Group COO, regenerative medicine expert. A graduate of Kansas City University of Physicians and Surgeons, affiliated with The Clara Barton Hospital Association Inc. in Hoisington, Kansas and Critical Imaging Associates in Topeka, Kansas.
.
Chile
•  Enrique Testart, M.D., trauma surgeon, pediatric microsurgeon, regenerative medicine specialist, surgeon/manager Innovassalud, S.A. German clinic in Santiago, founder, ConsortiaInnovas S.A., Global Stem Cells Group Chile CEODavid Audley, (U.S.) international consultant; fellow, Institute for Global Health and research, Chair, American Regenerative Technology Alliance (RTA).
.
U.S.
•  David Audley, international consultant; fellow, Institute for Global Health and research, Chair, American Regenerative Technology Alliance (RTA).
.
Following the conference, Global Stem Cells Group will conduct a special training course to include regenerative medicine body preparations using vitamin combinations and other nutritional supplements to enhance stem cell function.
The conference will take place at the Marriott Hotel in Santiago, AV. Pdte. Kennedy 5741 –Vitacura.
For more information on the 2016 International Academic Year Inaugural Convention in Santiago, Chile visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com or call 305-224-1858.
About Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Cellus Regenerative Medicine, SA.:
Cellus is dedicated to research, development and commercialization of therapeutic services and custom biotech products in the field of regenerative medicine. Their multidisciplinary team of stem cell experts focuses on the prevention and reversal of impairment in the skin of patients with traumatic injuries, skin diseases or symptoms of aging.
Their state-of-the-art facility in Santiago features a full laboratory and showcases the company’s extensive clinical expertise and biopharmaceutical production capabilities.
To view this press release live online, click here.
###